CUL4A and breast carcinoma: In addition, they described amplification of CUL4A (25.7%), LAMP1 (13.5%), TFDP1 (31.1%), and GAS6 (13.5%) by DNA qRT-PCR on a set of 74 human breast carcinomas [22].